BIG PHARMA WATCH: BRAND NAME DRUG MAKER TOUTS PATENT ABUSE PLAYBOOK THAT DELAYED ACCESS TO SAFER AND MORE EFFECTIVE TREATMENTS
Gilead CEO Touts Success of Company’s Patent Playbook on HIV Portfolio That… Read More
Gilead CEO Touts Success of Company’s Patent Playbook on HIV Portfolio That… Read More
Lawmakers Should Remain Focused on Holding Big Pharma Accountable for… Read More
Big Pharma Giants Conclude Latest Round of Earnings Reports Fueled by… Read More
Big Pharma Giants Keep Beating Wall Street Expectations While Continuing to… Read More
Big Pharma Giants Rolling in Strong Earnings While Continuing to Hike Drug… Read More
Big Pharma Giants Continue Reporting Expectation-Beating Q3 Earnings After… Read More
Eli Lilly Opinion Column Reiterates Debunked Arguments on Innovation as Brand… Read More
Johnson & Johnson Reports Higher-Than-Expected Earnings Fueled by Price… Read More
CBO Confirms Cost of Blockbuster Obesity Drugs at Current Prices Would… Read More
STAT Analysis Finds Drug Makers Gaming FDA Orange Book Process to Further… Read More
Lawmakers Should Remain Focused on Holding Big Pharma Accountable for… Read More
Legislation Scheduled for Thursday Markup Would Encourage Adoption of… Read More